2 terminated, 1 active not recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 2, Active not recruiting 1 |
Follow Multi-centric Castleman's Disease: new trials by email Literature Review of Multi-centric Castleman's Disease trials Research Report on Multi-centric Castleman's Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda Rituximab and Hyaluronidase Human, Cyclophosphamide, Vincristine - Burkitt Lymphoma, KSHV-associated Multicentric Castleman Disease | Phase 1 | Terminated | Fred Hutchinson Cancer Center | 18 | 2019-10-24 | 2024-01-03 |
| Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma liposomal doxorubicin, pomalidomide - Kaposi Sarcoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 62 | 2016-01-13 | 2026-08-28 |
| Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection Ibrutinib, Laboratory Biomarker Analysis, Pharmacological Study - Adult B Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia | Phase 1 | Terminated | National Cancer Institute (NCI) | 72 | 2014-09-01 | 2015-08-20 |
Burkitt Lymphoma (2) · Lymphoma, Large B-Cell, Diffuse (2) · Acquired Immunodeficiency Syndrome (1) · HIV Infections (1) · Intraocular Lymphoma (1) · Leukemia, Hairy Cell (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large-Cell, Immunoblastic (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
DNA Virus Infections (3) · Herpesviridae Infections (3) · Immune System Diseases (3) · Infections (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Virus Diseases (3) · Blood-Borne Infections (2) · Communicable Diseases (2) · Epstein-Barr Virus Infections (2) · Genital Diseases (2) · Hemic and Lymphatic Diseases (2) · Immunologic Deficiency Syndromes (2) · Immunoproliferative Disorders (2) · Lentivirus Infections (2)
CT-P10 (1) · Cyclophosphamide (1) · Doxorubicin (1) · Etoposide (1) · Hyaluronoglucosaminidase (1) · Methotrexate (1) · Prednisone (1) · Rituximab (1) · Vincristine (1) · deltacortene (1) · ibrutinib (1) · liposomal doxorubicin (1) · pomalidomide (1)
National Cancer Institute (NCI) (2) · Fred Hutchinson Cancer Center (1)
United States (2) · Uganda (1)
Manoj Menon, MD (1) · Ramya M Ramaswami, M.D. (1) · Yvette Kasamon (1)
U01CA121947 (1)